Dr. Pioro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
259 E Erie St
Ste 1900
Chicago, IL 60611Phone+1 312-695-7950Fax+1 312-695-5747
Education & Training
Cleveland Clinic FoundationFellowship, Neuromuscular Medicine (Neurology), 1993 - 1995
Montreal Neurological Institue & Hospital, McGill University, Montreal PQResidency, Neurology Residency, 1990 - 1993- Dept of Pharmacology & Therapeutics, McGill University, Montreal PQPost-Doctoral Fellowship, 1986 - 1990
Mayo Clinic College of Medicine and Science (Rochester)Residency, Pathology-Anatomic and Clinical, 1985 - 1986- University of OxfordD.Phil., Neuroanatomy/Neuropathology, Ph.D, 1981 - 1983
University of Calgary Faculty of MedicineClass of 1981
Certifications & Licensure
IL State Medical License 2021 - 2026
OH State Medical License 1994 - 2026
MN State Medical License 1985 - 1986
Fellow of the Royal College of Physicians and Surgeons, CanadaNeurology
Awards, Honors, & Recognition
- Barry Winovich Endowed Chair in ALS Research Lerner Research Institute, Cleveland Clinic
- Professor of Neurology Cleveland Clinic Lerner College of Medicine of CWRU, 2019
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Join now to see all
Clinical Trials
- Clinical Trial Nuedexta in Subjects With ALS Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 1 citationsGraph theory network analysis reveals widespread white matter damage in brains of patients with classic ALS.Venkateswaran Rajagopalan, Erik P Pioro
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-02-01 - Modeling ALS with Patient-Derived iPSCs: Recent Advances and Future Potentials.Ladan Dawoody Nejad, Erik P Pioro
Brain Sciences. 2025-01-30 - 1 citationsEfficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statis...Erik P Pioro, Benjamin Rix Brooks, Ying Liu, Jeffrey Zhang, Stephen Apple
Journal of the Neurological Sciences. 2024-12-15
Press Mentions
Treatment That May Slow ALS Funded in Part by Ice Bucket ChallengeSeptember 3rd, 2020- New Treatment May Help Slow Progression of ALS, Research ShowsSeptember 3rd, 2020
Depression Affects Quality of Life, Mortality in ALSFebruary 23rd, 2016- Join now to see all
Grant Support
- Motor Neuron Degeneration In A Model Of ALSNational Institute Of Neurological Disorders And Stroke1995–1999
Professional Memberships
- Member
- Member
Other Languages
- Russian, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
